INTENSITY THERAPEUTICS, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-11
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$1.68M.
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$1.66M.
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$1.10M.
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$696.00K.
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $9.33M.
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$5.97M, a 182.36% decline from fiscal 2023.
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $7.24M.
- INTENSITY THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$3.23M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.39M 10-Q · filed 2026-08-11 | |||||
| 2026-03-31 | -$1.68M 10-Q · filed 2026-05-07 | |||||
| 2025-12-31 | $9.33M 10-K · filed 2026-03-27 | |||||
| 2025-09-30 | $4.48M 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | -$374.00K 10-Q · filed 2026-08-11 | |||||
| 2025-03-31 | -$1.66M 10-Q · filed 2026-05-07 | |||||
| 2024-12-31 | -$5.97M 10-K · filed 2026-03-27 | |||||
| 2024-09-30 | -$5.77M 10-Q · filed 2025-11-06 | |||||
| 2024-06-30 | -$5.32M 10-Q · filed 2025-08-07 | |||||
| 2024-03-31 | -$1.10M 10-Q · filed 2025-05-13 | |||||
| 2023-12-31 | $7.24M 10-K · filed 2025-03-13 | |||||
| 2023-09-30 | $5.38M 10-Q · filed 2024-11-13 | $5.38M 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | -$1.18M 10-Q · filed 2024-08-08 | -$1.18M 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$696.00K 10-Q · filed 2024-05-09 | |||||
| 2022-12-31 | -$3.23M 10-K · filed 2024-03-14 | |||||
| 2022-09-30 | -$3.84M 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$2.82M 10-Q · filed 2023-08-14 |